Middle-East and Africa Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Middle-East and Africa Vaccine Adjuvant Market by Type (Aluminium Salts, Tensoactive Adjuvants, Adjuvant Emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants) by Route of Administration (Oral, Intradermal, Subcutaneous, Intranasal and Intramuscular), by Mechanism of Action (Immuno Stimulants, Carriers and Vehicle Adjuvants) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 682 | Pages: 140 | October 2016 | Region: Middle East and Africa


The Middle-East and Africa Vaccine Adjuvant Market was worth $47.20 million in 2016 and estimated to be growing at a CAGR of 10.6%, to reach $78.12 million by 2021.

The Adjuvants are immunological or pharmacological agents that supports in synergizing and leading the adaptive immune response to vaccine agents. The problem with unadulterated recombinant or engineered antigens used as a part of innovative vaccinations is that they are far less immunogenic than more experienced style live or slaughtered complete living being antibodies. This has made a notable requirement for improved and all the more powerful adjuvants for use in these immunizations.

The major factors subsidising to the growth of the vaccine adjuvants market consist of growing government finance for research, high occurrence of diseases, escalating biotechnology and biopharmaceutical industries, and rising emphasis on improved vaccination. Moreover, increasing R&D expenditure as well as acquisitions, associations, and alliances by companies is another major factor driving the growth of this market.

The Middle-East and Africa vaccine adjuvants market is segmented on the basis of type into Aluminium Salts, Tensoactive Adjuvants, Adjuvant emulsions, Bacteria derived Adjuvants, Liposome Adjuvants and Carbohydrate Adjuvants. Based on route of administration, the market is divided into oral, intradermal, subcutaneous, intranasal and intramuscular. The market is bifurcated on the basis of mechanism of action into active immuno stimulants, carriers and vehicle adjuvants. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.    

Based on geography the market is analysed under various regions namely, Middle-East and Africa. Middle-East is estimated to dominate the regions vaccine adjuvant market in the forecast period.

The key players in the vaccine adjuvants market include MPV Technologies (U.S.), Avanti Polar Lipids, Novavax Inc. (U.S.), Inc. (U.S.), Brenntag Biosector (Denmark), SEPPIC (France), Agenus, Inc. (U.S.), Invivogen (U.S.), SPI Pharma, Inc. (U.S.), CSL Limited (Australia), and OZ Biosciences (France).

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Vaccine Adjuvant Market By Region, From 2016-2021 (USD Million)
  2. Middle East & Africa Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  3. Middle East & Africa Aluminium Salts Market By Region, From 2016-2021 (USD Million)
  4. Middle East & Africa Tensoactive Adjuvants Market By Region, From 2016-2021 (USD Million)
  5. Middle East & Africa Adjuvant Emulsions Market By Region, From 2016-2021 (USD Million)
  6. Middle East & Africa Bacteria derived Adjuvants Market By Region, From 2016-2021 (USD Million)
  7. Middle East & Africa Liposome Adjuvants Market By Region, From 2016-2021 (USD Million)
  8. Middle East & Africa Carbohydrate Adjuvants Market By Region, From 2016-2021 (USD Million)
  9. Middle East & Africa Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  10. Middle East & Africa Oral Market By Region, From 2016-2021 (USD Million)
  11. Middle East & Africa Intradermal Market By Region, From 2016-2021 (USD Million)
  12. Middle East & Africa Subcutaneous Market By Region, From 2016-2021 (USD Million)
  13. Middle East & Africa Intranasal Market By Region, From 2016-2021 (USD Million)
  14. Middle East & Africa Intramuscular Market By Region, From 2016-2021 (USD Million)
  15. Middle East & Africa Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  16. Middle East & Africa Immuno Stimulants Market By Region, From 2016-2021 (USD Million)
  17. Middle East & Africa Carriers Market By Region, From 2016-2021 (USD Million)
  18. Middle East & Africa Vehicle Adjuvants Market By Region, From 2016-2021 (USD Million)
  19. Middle East Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  20. Middle East Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  21. Middle East Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
  22. Africa Vaccine Adjuvant Market By Type, From 2016-2021 (USD Million)
  23. Africa Vaccine Adjuvant Market By Route of Administration , From 2016-2021 (USD Million)
  24. Africa Vaccine Adjuvant Market By Mechanism of Action, From 2016-2021 (USD Million)
Middle East And Africa Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Applic...
Latin America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Res...
Europe Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research ...
North America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Radioimmunoassay Market By Type (Reagents And Kits Market, Analysers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Cli...
Middle East And Africa Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, G...
Latin America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Asia Pacific Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Ele...
Europe Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrica...
North America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimu...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.